Essex Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$642K Sell
7,404
-2,247
-23% -$215K 0.1% 161
2025
Q4
$927K Hold
9,651
0.14% 144
2025
Q3
$919K Buy
+9,651
New +$887K 0.14% 147
2023
Q3
Sell
-10,245
Closed -$903K 381
2023
Q2
$903K Buy
+10,245
New +$882K 0.13% 221
2020
Q4
Sell
-50
Closed -$5K 499
2020
Q3
$5K Buy
+50
New +$5.02K ﹤0.01% 461
2019
Q3
Sell
-265
Closed -$26K 490
2019
Q2
$26K Hold
265
﹤0.01% 424
2019
Q1
$24K Hold
265
﹤0.01% 427
2018
Q4
$24K Buy
+265
New +$24.8K ﹤0.01% 421
2016
Q3
Sell
-9,117
Closed -$791K 350
2016
Q2
$791K Buy
+9,117
New +$737K 0.13% 181

Other funds holding MDT

Essex Investment Management's MDT Position: Q1 2026 in Review

Essex Investment Management reduced its Medtronic (MDT) stake by 23% in Q1 2026, selling an estimated $215K and leaving 7,404 shares worth $642K. The position accounts for 0.1% of the portfolio, ranked #161.

Essex Investment Management first reported a position in MDT in Q2 2016 and has held it in 9 quarters since. The position peaked at $927K in Q4 2025. 2,237 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Essex Investment Management held 7,404 shares of Medtronic worth $642K as of Q1 2026.
  • Essex Investment Management sold 2,247 Medtronic shares in Q1 2026, an estimated $215K.
  • Medtronic made up 0.1% of Essex Investment Management's portfolio in Q1 2026, its #161 holding.
  • Essex Investment Management first reported a position in Medtronic in Q2 2016 and has held it in 9 quarters since.
  • Essex Investment Management's Medtronic position peaked at $927K in Q4 2025.
  • 2,237 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.